E
Endovascular Engineering
Health Tech & Medtech · Menlo Park, United States · Founded 2019
Vascular thrombectomy solutions enhancing patient outcomes through innovative medical devices MoreLess
Endovascular Engineering is a venture-funded medical device startup in stealth mode, focused on developing advanced vascular thrombectomy solutions. These devices are designed to remove blood clots from blood vessels, thereby improving patient outcomes in critical medical situations. The company operates in the medical technology market, primarily serving healthcare providers such as hospitals and clinics that require cutting-edge tools for vascular procedures. Endovascular Engineering's business model revolves around the research, development, and eventual commercialization of these medical devices. Revenue is generated through the sale of these devices to healthcare institutions and potentially through partnerships or licensing agreements with larger medical technology firms. The company is based in Menlo Park, California, and is actively seeking talented and passionate individuals to join their team. Keywords: vascular thrombectomy, medical devices, venture-funded, stealth mode, healthcare, innovation, patient outcomes, Menlo Park, startups, medical technology.
Company overview
Endovascular Engineering company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Menlo Park, United States
- Employees
- 41
- Open positions
- None listed
- Dealroom signal
- 89.9
Valuation & funding
Endovascular Engineering funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Apr 2026 | $80M | $320M | Panakès Partners · Gilde Healthcare · Norwest Venture Partners · S3 Ventures | ↗ |
| SERIES BOther financing | Feb 2025 | $42M | $168M | Panakès Partners · M&L Group · Sante Ventures · S3 Ventures | ↗ |
| SERIES AOther financing | Apr 2022 | $15M | $60M | Sante Ventures · Cordis | ↗ |
| SPINOUTOther financing | Feb 2019 | $0 | — | University of Michigan | — |
Growth signals
Endovascular Engineering website traffic
Latest recorded traffic for Endovascular Engineering is 850 monthly website visits, down 66% over the last three months. Endovascular Engineering's team grew 10.8% over the past year.
Comparisons
Endovascular Engineering compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Endovascular Engineering's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Endovascular Engineering has talent and traffic
team presence
In the news
Latest news about Endovascular Engineering
Recent press, funding announcements, and product moves mentioning Endovascular Engineering — open to read from the original sources.
Market sentiment
What the market is saying about Endovascular Engineering
An AI-synthesized read of the highest-engagement posts about Endovascular Engineering on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Endovascular Engineering’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.